Mumbai terror attacks hit pharma investment

The recent terrorist attacks in Mumbai, India, have dented local confidence in the prospects of inward investment for the pharmaceutical industry, according to a report in the Business Standard. One immediate effect was the cancellation of the CPhI India exhibition in the city, which had been due to open a couple of days after the events of November 26. This had been an opportunity for local contract drug companies to develop contacts with foreign clients. The same venue, the Bombay Exhibition Center, was also to host P-MEC, an important conference for Indian pharmaceutical manufacturing equipment firms.